EU Commission Wants Expert Opinion On Prostaglandin Analogs In Eyelash Growth Cosmetics
Executive Summary
The Scientific Committee on Consumer Safety will consider available safety data for prostaglandin analogs isopropyl cloprostenate, ethyl tafluprostamide and others with known use in eyelash-growth cosmetic products in the EU. Currently, the substances are not restricted in cosmetic products.
You may also be interested in...
European Commission Examining Prostaglandins In Cosmetics: Are They Safe? Are They Drugs?
Marketers of cosmetic products that rely on prostaglandins or their analogues to grow eyelashes – or compete against companies that use the ingredients – have until 22 October to submit information to the Commission, which will help inform an assessment by the Scientific Committee on Consumer Safety.
‘The Dark Side’ Of Green Packaging: Cosmetics Technical Expert On Challenges And Potential Risks
Presenting at the Independent Beauty Association’s Cosmetic Technical/Regulatory Forum, Product Integrity Laboratory’s Howard Baker dug into the less-discussed aspects of green packaging that “could damage your brand’s reputation, cause regulatory and legal problems, and severely harm the economics of your business.”
CIR ‘Watchdog’ Women’s Voices For The Earth To Remain On Guard In 2021
NGO says the Expert Panel for Cosmetic Ingredient Safety’s conclusion on methylisothiazolinone in 2020 was among decisions “not in the interest of public health.” However, other assessments highlighted by the group suggest that the Cosmetic Ingredient Review is working as an open forum for public input and discussion.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: